510(k) Report

510(k) · Cleared

Cleared

Spiral Flow Peripheral Vascular Graft

K150389510(k) SpecialCleared May 6, 201577-day reviewClass II21 CFR 870.3450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vascular Flow Technologies, Ltd. · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on May 6, 2015 as substantially equivalent to K083169 (Tayside Flow Technologies Limited, 2009) and 1 other predicate after a 77-day review. Its family tree reaches back 4 generations to 1998.

Decided
May 6, 2015
Review
77 days
Class
Class II
Product code
DSY
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K983861 (1998). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK983861 Distaflo Bypass GraftImpra, Inc. · 1998 · Recalled
  2. 3 generations backK050049 Dynaflo Bypass GraftBard Peripheral Vascular, Inc. · 2005
  3. 2 generations backK083169 Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited · 2009
  4. 1 generation backK142062 Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2014
  5. This deviceK150389 Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K983861Distaflo Bypass GraftImpra, Inc.19982
−3K050049Dynaflo Bypass GraftBard Peripheral Vascular, Inc.2005—
−2K083169Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited2009—
−1K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.2014—
0 (this device)K150389Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200520
FIG. 1 — Lineage of K150389, 1998–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K083169Eptfe Slftm Spiral Vascular Graft
Summary page 5
…ce for implantation. Predicate Device: The modified device is substantially equivalent to the previously cleared Spiral Flow Peripheral Vascular Grafts, 510(k) numbers K083169 and K142062. Device Description: Vascular Flow Technologies’ (VFT) Spiral Flow™ Peripheral Vascular Graft is to be used in the…
Tayside Flow Technologies Limited2009—
*K142062Spiral Flow Peripheral Vascular Graft
Summary page 5
…ntation. Predicate Device: The modified device is substantially equivalent to the previously cleared Spiral Flow Peripheral Vascular Grafts, 510(k) numbers K083169 and K142062. Device Description: Vascular Flow Technologies’ (VFT) Spiral Flow™ Peripheral Vascular Graft is to be used in the bypass or re…
Vascular Flow Technologies, Ltd.2014—

Also cleared against K083169: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 5.6 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K083169.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

The Spiral Flow Peripheral Vascular Grafts are indicated for use as vascular prostheses.

The device is intended for use in the bypass or reconstruction of occluded or diseased peripheral arterial blood vessels above or below the knee. Graft configurations are intended for use as arterial conduits for bypass, or reconstruction of peripheral arterial blood vessels.

ONLY trained and qualified physicians and/or surgeons, under the controlled conditions of a hospital operating theatre environment are indicated for use of this device for implantation.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K150389: Spiral Flow Peripheral Vascular Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150389

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026